Source: Annual Congress 2001 - Long-acting β2-agonists: clinical effects
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Gabrijelcic, A. Casas, R. Rabinovich, A. Acuña, J. A. Barbera, J. Roca, K. F. Chung, R. Rodriguez-Roisin (Barcelona, Spain; London, United Kingdom). Formoterol protects against platelet-activating factor-induced lung function abnormalities in asthma. Eur Respir J 2001; 16: Suppl. 31, 3476

Member's Comments

No comment yet.

Related content which might interest you: Formoterol protects against platelet-activating factor-induced effects in asthma Source: Eur Respir J 2004; 23: 71-75 Year: 2004 Hepatocyte growth factor attenuates airway hyperresponsiveness and airway inflammation in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 27s Year: 2002 Effects of platelet-activating factor (PAF) challenge on airway neutrophilia and adhesion molecules in mild asthma Source: Eur Respir J 2001; 18: Suppl. 33, 163s Year: 2001 Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma Source: Eur Respir J 2002; 19: 872-878 Year: 2002 Hepatocyte growth factor prevents airway remodelling in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 194s Year: 2003 Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function Source: Eur Respir J 2007; 30: Suppl. 51, 495s Year: 2007 Protective effects of keratinocyte growth factor-2 on lipopolysacchride-induced acute lung injury Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010 Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy Source: Eur Respir J 2014; 43: 1211-1212 Year: 2014 Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy Source: Eur Respir J 2014; 43: 1208-1211 Year: 2014 Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy Source: Eur Respir J 2013; 42: 350-361 Year: 2013 Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats Source: Eur Respir J 2007; 30: 31-39 Year: 2007 Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats Source: Eur Respir J 2006; 27: 726-734 Year: 2006 Effects of the lectin-like domain of TNF and terbutaline on the deterioration of airway and tissue mechanics in a porcine model of acute lung injury Source: Eur Respir J 2005; 26: Suppl. 49, 221s Year: 2005 Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD Source: Eur Respir J 2011; 38: 789-796 Year: 2011 Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 24s Year: 2007 Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression Source: Eur Respir J 2003; 22: 290-297 Year: 2003 Different inhaled corticosteroids altered lung microbiome and regulating the expression of PAF receptor as well as the phagocytosis function of macrophage Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Montelukast inhibits bronchoconstriction and gas exchange defects induced by leukotriene D4 challenge in asthma Source: Eur Respir J 2002; 20: Suppl. 38, 308s Year: 2002 Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008